sacituzumab

CHEBI:CHEBI_753786

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2360539
generic_name
SACITUZUMAB GOVITECAN
product_type
BULK INGREDIENT
listing_expiration_date
20251231
marketing_start_date
20200422
dosage_form
POWDER, FOR SOLUTION
route
INTRAVENOUS
active_ingredient_strength
200 kg/200kg
package_marketing_start_date
14-AUG-20
marketing_category
BULK INGREDIENT
labeler_name
Gilead Sciences
active_ingredient_name
SACITUZUMAB
product_ndc
55135-132
spl_id
9fc1d7a0-cf3a-4075-8e15-3c6a95070da9
package_ndc
55135-132-01
package_description
1 VIAL in 1 BOX (55135-132-01) / 1 POWDER, FOR SOLUTION in 1 VIAL
brand_name
TRODELVY
brand_name_base
TRODELVY
application_number
BLA761115
manufacturer_name
Gilead Sciences
unii
M9BYU8XDQ6
spl_set_id
57a597d2-03f0-472e-b148-016d7169169d
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class